Patents by Inventor Motowo Tomita

Motowo Tomita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7435551
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: October 14, 2008
    Assignee: Fujirebio, Inc.
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi Hirose, Koichi Matsubara
  • Patent number: 7067634
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: June 27, 2006
    Assignee: Rebio Gen, Inc.
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi HIrose, Koichi Matsubara
  • Publication number: 20050266506
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Application
    Filed: June 22, 2005
    Publication date: December 1, 2005
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi Hirose, Koichi Matsubara
  • Publication number: 20050048565
    Abstract: This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
    Type: Application
    Filed: August 16, 2002
    Publication date: March 3, 2005
    Inventors: Motowo Tomita, Yasuko Nakano, Hiroshi Hirose, Koichi Matsubara
  • Patent number: 5795736
    Abstract: Genes coding for a protein having human MACIF activity, expression vectors containing the genes, transformed cells with the vectors and proteins having human MACIF activity.
    Type: Grant
    Filed: August 11, 1995
    Date of Patent: August 18, 1998
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Motowo Tomita, Yuji Sugita, Toshiyuki Takemoto, Kiyoshi Furuichi, Makoto Takayama, Ko Yasukawa, Katsuhisa Ito, Noboru Yamaji, Shinya Yano
  • Patent number: 5532339
    Abstract: Fusion proteins comprising the extracellular domain of the human MACIF (Membrane Attack Complex Inhibition Factor) gene product and a heterologous phosphatidylinositol (PI) anchor domain are provided.
    Type: Grant
    Filed: August 17, 1994
    Date of Patent: July 2, 1996
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Motowo Tomita, Yuji Sugita, Toshiyuki Takemoto, Kiyoshi Furuichi, Makoto Takayama, Ko Yasukawa, Katsuhisa Ito, Noboru Yamaji, Shinya Yano